-
Mugglehead
Jun 28, 2022, 10:13 pm286 ptsA renowned biopharmaceutical company has received a “may proceed” letter for its new clinical trial examining the effects of an altered psilocybin compound on mental health. On Monday, Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) announced that it had been granted Investigational New Drug (IND) application…
Trending Today on NewsBudz
NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.
Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.